EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 20 June 2019

European Healthcare: So much we can build on, so much left to do

A blog by Stefan Oschmann

A blog by Stefan Oschmann, EFPIA President, Chairman of the Executive Board and CEO of Merck

Europe has made great progress in healthcare in recent years. An EU citizen born today can expect to live 30 years longer than his or her ancestors a century ago. And much suggests that this trend will persist. From immuno-oncology to gene and cell therapy, we are seeing new medicines that give hope to patients who until recently have had no treatment options.

I am convinced that there has never been a more promising time for pharmaceutical innovation. Thanks to the digital revolution and new biotechnologies, we now have tools at our disposal that we would not have dared to dream about just a few years ago. Read more

News

EU Health Coalition calls upon the European Council to increase the total Horizon Europe budget...
19 June 2019

Ahead of the European Council Meeting (20-21 June), the EU Health Coalition calls upon Member States to adopt a Multiannual... Read more

Working together for patients
20 June 2019

Pharmaceutical companies continue to drive transparency and underline industry investment in Europe’s healthcare Read more

Blogs

The story behind the numbers
20 June 2019 - Nathalie Moll

This week EFPIA produced its annual statistics report. What is the story behind the numbers? What are we seeing as the... Read more

Rare & childhood diseases: addressing unmet need
14 June 2019 - Nathalie Moll

With the right framework in place we can continue to work together to meet the needs of children and adults living with... Read more

New study on sustainability of the European off-patent biologics market
17 June 2019 - Nathalie Moll

A new study by the Pugatch Consilium, commissioned by EFPIA, shows that many European countries are focusing on maximising... Read more

Harnessing Real-World Data: Are We There Yet? (Guest blog)
17 June 2019 - Nigel Hughes

For the most part, today’s health data landscape is still lingering in the 20th century. It consists largely of a myriad... Read more

Videos

EFPIA Manifesto: Building a healthier future for Europe
We have a vision for a healthier world. We can see a brighter tomorrow for all patients. #WeWontRest until we get there.... Read more

Protect The Spark
Every new treatment or cure starts with the spark of an idea. That spark has to be nurtured and cared for through the... Read more

For The Chance To...
Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the... Read more

ENABLE Call for Action - European Gram-negative Antibacterial Engine
The ENABLE consortium is working to advance the development of promising new antibiotic compounds targeting Gram-negative... Read more

Events

EFPIA 2019 Annual Conference
27 June 2019 (Radisson Blu Royal Hotel, Brussels, Belgium)

Making connections can advance patient care and support the European economy at a time of significant change and challenge... Read more

WIN 2019 Symposium
23 June 2019 (Paris, France)

A symposium dedicated to Innovation and global deployment of Precision Oncology Read more

EURORDIS Black Pearl Awards 2020

NOMINATIONS for the EURORDIS Black Pearl Awards 2020
On 20 June 2019 (EURORDIS Black Pearl Awards)

Taking place in February to mark the occasion of Rare Disease Day, this event celebrates the inspirational qualities... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu